These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28899686)

  • 1. The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies.
    Kasprick A; Holtsche MM; Rose EL; Hussain S; Schmidt E; Petersen F; Panicker S; Ludwig RJ
    J Invest Dermatol; 2018 Feb; 138(2):458-461. PubMed ID: 28899686
    [No Abstract]   [Full Text] [Related]  

  • 2. Bullous pemphigoid autoantibody-mediated complement fixation is abolished by the low-molecular-weight heparin tinzaparin sodium.
    Gutjahr A; Heck F; Emtenani S; Hammers AK; Hundt JE; Muck P; Siegel DL; Schmidt E; Stanley JR; Zillikens D; Hammers CM
    Br J Dermatol; 2019 Sep; 181(3):593-594. PubMed ID: 31124130
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab.
    Fairley JA; Baum CL; Brandt DS; Messingham KA
    J Allergy Clin Immunol; 2009 Mar; 123(3):704-5. PubMed ID: 19152970
    [No Abstract]   [Full Text] [Related]  

  • 4. Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid.
    Kamata M; Asano Y; Shida R; Maeda N; Yoshizaki A; Miyagaki T; Kawashima T; Tada Y; Sato S
    J Dermatol; 2019 Jun; 46(6):e216-e217. PubMed ID: 30628103
    [No Abstract]   [Full Text] [Related]  

  • 5. Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid.
    Menzinger S; Kaya G; Schmidt E; Fontao L; Laffitte E
    Acta Derm Venereol; 2018 Feb; 98(2):284-286. PubMed ID: 29136264
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid.
    Kamiya K; Aoyama Y; Noda K; Miyake T; Yamaguchi M; Hamada T; Tokura Y; Iwatsuki K
    J Dermatol Sci; 2015 Apr; 78(1):77-9. PubMed ID: 25771164
    [No Abstract]   [Full Text] [Related]  

  • 7. Bullous pemphigoid induced by pembrolizumab in a patient with advanced melanoma expressing collagen XVII.
    Wada N; Uchi H; Furue M
    J Dermatol; 2017 Oct; 44(10):e240-e241. PubMed ID: 28677843
    [No Abstract]   [Full Text] [Related]  

  • 8. Atezolizumab-induced lichen planus pemphigoides in a patient with metastatic non-small-cell lung cancer.
    Senoo H; Kawakami Y; Yokoyama E; Yamasaki O; Morizane S
    J Dermatol; 2020 Apr; 47(4):e121-e122. PubMed ID: 31984550
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-collagen XVII single-chain Fv antibody blocks the autoimmune reaction mediated by pathogenic autoantibodies in bullous pemphigoid.
    Wu Y; Sun NN; Dang EL; Jin L; Liu ZF; Zhang W; Yang LT; Wang G
    J Dermatol Sci; 2013 Oct; 72(1):25-31. PubMed ID: 23827201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated IL-31 serum levels in bullous pemphigoid patients correlate with eosinophil numbers and are associated with BP180-IgE.
    Salz M; Haeberle S; Hoffmann J; Enk AH; Hadaschik EN
    J Dermatol Sci; 2017 Sep; 87(3):309-311. PubMed ID: 28823642
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180.
    Osawa M; Ueda-Hayakawa I; Isei T; Yoshimura K; Fukuda S; Hashimoto T; Okamoto H
    J Am Acad Dermatol; 2014 Jun; 70(6):e129-31. PubMed ID: 24831331
    [No Abstract]   [Full Text] [Related]  

  • 12. Case of bullous pemphigoid coexisting with anti-desmoglein autoantibodies.
    Tie D; Yoshida T; Chinuki Y; Da X; Ishikawa N; Morita E
    J Dermatol; 2017 Jul; 44(7):822-825. PubMed ID: 28342216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating IgE anti-BP180 autoantibody and its correlation to clinical and laboratorial aspects in bullous pemphigoid patients.
    Ma L; Wang M; Wang X; Chen X; Zhu X
    J Dermatol Sci; 2015 Apr; 78(1):76-7. PubMed ID: 25797173
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of pemphigoid vegetans with autoantibodies against both BP180 and BP230 antigens.
    Suda-Takayanagi T; Hara H; Ohyama B; Hashimoto T; Terui T
    J Am Acad Dermatol; 2011 Jan; 64(1):206-8. PubMed ID: 21167421
    [No Abstract]   [Full Text] [Related]  

  • 15. Bullous pemphigoid autoantibodies directly induce blister formation without complement activation.
    Ujiie H; Sasaoka T; Izumi K; Nishie W; Shinkuma S; Natsuga K; Nakamura H; Shibaki A; Shimizu H
    J Immunol; 2014 Nov; 193(9):4415-28. PubMed ID: 25261486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous pemphigoid with hyperkeratosis and palmoplantar keratoderma: Three cases.
    Fania L; Didona D; Pacifico V; Mariotti F; De Luca N; Abeni D; Mazzanti C; Di Zenzo G; Didona B
    J Dermatol; 2018 Sep; 45(9):1135-1140. PubMed ID: 30007013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of circulating immunoglobulin E autoantibodies against BP180 and BP230 in an intractable case of bullous pemphigoid.
    Akasaka E; Hagiwara C; Takiyoshi N; Aizu T; Nakano H; Sawamura D; Ota T
    J Dermatol Sci; 2016 Oct; 84(1):110-113. PubMed ID: 27492811
    [No Abstract]   [Full Text] [Related]  

  • 18. Case of atypical bullous pemphigoid with generalized pruritus and eczema as the prodrome for 10 years.
    Ikeda T; Okamoto K; Furukawa F
    J Dermatol; 2012 Aug; 39(8):720-1. PubMed ID: 22011062
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenesis of bullous pemphigoid.
    Ujiie H; Nishie W; Shimizu H
    Immunol Allergy Clin North Am; 2012 May; 32(2):207-15, v. PubMed ID: 22560134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous IgG Reduces Pathogenic Autoantibodies, Serum IL-6 Levels, and Disease Severity in Experimental Bullous Pemphigoid Models.
    Sasaoka T; Ujiie H; Nishie W; Iwata H; Ishikawa M; Higashino H; Natsuga K; Shinkuma S; Shimizu H
    J Invest Dermatol; 2018 Jun; 138(6):1260-1267. PubMed ID: 29391250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.